Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.
Zbigniew SiudakMarek GrygierWojciech WojakowskiKrzysztof P MalinowskiAdam WitkowskiMariusz GąsiorDariusz DudekStanisław BartuśPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Due to SARS-CoV-2 pandemic there was an absolute reduction in the number of interventional procedures both acute and elective in comparison to 2019 and a significant shift into acute procedures. COVID-19 confirmed/suspected patients do not differ in terms of procedural and baseline characteristics and reveal similar outcomes when treated with percutaneous coronary interventions.
Keyphrases
- sars cov
- coronavirus disease
- liver failure
- respiratory syndrome coronavirus
- coronary artery disease
- coronary artery
- end stage renal disease
- newly diagnosed
- respiratory failure
- ejection fraction
- physical activity
- minimally invasive
- chronic kidney disease
- drug induced
- aortic stenosis
- ultrasound guided
- prognostic factors
- peritoneal dialysis
- hepatitis b virus
- patient reported outcomes
- adipose tissue
- atrial fibrillation
- skeletal muscle
- acute respiratory distress syndrome
- transcatheter aortic valve replacement
- dna methylation
- metabolic syndrome
- patient reported
- weight loss